NeuroSense Therapeutics NRSN
NASDAQ NRSN
$2.46 +0.02 (+0.82%)
At close: Oct 23, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Short-term Investments (2022 - 2023)

Updated

NeuroSense Therapeutics' Short-term Investments came in at $3.05 million for Q1 2023, down 39.0% from $5 million a year earlier and down 13.9% from the prior quarter.

Analysis

NeuroSense Therapeutics (NRSN) Short-term Investments (2022 - 2023) Analysis & Trends

At the end of FY2022, NeuroSense Therapeutics' Short-term Investments was $3.55 million.

  • Business Quant data shows NRSN's Short-term Investments at $3.55 million (Q4 2022), $4.03 million (Q3 2022) and $6.03 million (Q2 2022) in the three quarters before Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 NeuroSense Therapeutics 3.08 Mn -1.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 3.05 Mn
Dec 31, 2022 3.55 Mn
Sep 30, 2022 4.03 Mn
Jun 30, 2022 6.03 Mn
Mar 31, 2022 5.00 Mn
API Access

NeuroSense Therapeutics Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=NRSN&period=max&api_key=YOUR_API_KEY